MMED · Minimed Group, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '26 |
|---|---|
| Revenue | $687.00M |
| Cost of Revenue | $292.00M |
| Gross Profit | $395.00M |
| R&D | $112.00M |
| SG&A | $268.00M |
| Total Operating Expenses | - |
| D&A | - |
| Operating Income | $21.00M |
| Interest Expense | - |
| Income Tax | $28.00M |
| Net Income | ($10.00M) |
| EPS - Basic | ($0.04) |
| EPS - Diluted | ($0.04) |
Balance Sheet
| Line item | Q3 '26 |
|---|---|
| Cash & Equivalents | $11.00M |
| Accounts Receivable | $570.00M |
| Inventory | $311.00M |
| Accounts Payable | $205.00M |
| Current Assets | $939.00M |
| Total Assets | $4.20B |
| Current Liabilities | $710.00M |
| Long-term Debt | - |
| Total Liabilities | $871.00M |
| Stockholders' Equity | $3.45B |
| Retained Earnings | - |
Cash Flow
| Line item | Q3 '26 |
|---|---|
| Operating Cash Flow | - |
| Investing Cash Flow | - |
| Financing Cash Flow | - |
| CapEx | - |
| Free Cash Flow | - |
Ratios
| Metric | Q3 '26 |
|---|---|
| Profitability | |
| Gross margin | 57.5% |
| Operating margin | 3.1% |
| EBITDA margin | - |
| Net margin | -1.5% |
| Free cash flow margin | - |
| FCF / Net income | - |
| R&D / Revenue | 16.3% |
| SG&A / Revenue | 39.0% |
| Effective tax rate | 155.6% |
| Return on assets | -0.2% |
| Return on equity | -0.3% |
| Return on invested capital | - |
| Liquidity | |
| Current ratio | 1.32 |
| Quick ratio | 0.88 |
| Cash ratio | 0.02 |
| Leverage | |
| Debt / Equity | - |
| Debt / Assets | - |
| Debt / EBITDA | - |
| Interest coverage | - |
| Equity multiplier | 1.22 |
| Liabilities / Assets | 0.21 |
| Efficiency | |
| Asset turnover | 0.16 |
| Inventory turnover | 0.94 |
| Days sales outstanding | 303d |
| Days inventory outstanding | 389d |
| Days payable outstanding | 256d |
| Cash conversion cycle | 435d |
| Valuation | |
| P / E | - |
| P / B | - |
| P / S | - |
| EV / EBITDA | - |
| Growth | |
| Revenue growth (YoY) | - |
| Revenue CAGR (3y) | - |
| Revenue CAGR (5y) | - |
| Gross profit growth (YoY) | - |
| Operating income growth (YoY) | - |
| Net income growth (YoY) | - |
| EPS growth (YoY) | - |
| EPS CAGR (3y) | - |
| EPS CAGR (5y) | - |
| FCF growth (YoY) | - |
| FCF CAGR (5y) | - |
| Book value growth (YoY) | - |
Peer comparison
Same SIC group: Surgical & Medical Instruments & Apparatus
Comparing MiniMed Group against the 5 most active filers in the same SIC group.